为评估混合物毒性的有效度估计的每日变化进行调整
Franziska Kappenberg1,2, Tim Brecklinghaus3, Leonie Schürmeyer4
1Department of Statistics, TU Dortmund University, Vogelpothsweg 87, 44227, Dortmund, Germany. kappenberg@statistik.tu-dortmund.de.
Archives of toxicology
|August 19, 2025
概括
由于人类同时暴露,评估化学混合物的毒性至关重要. 这项研究引入了一种新的方法,用于调整混合物毒性测试中的实验变异性,提高准确性.
科学领域:
- 毒理学 毒理学 毒理学
- 在体外试验测试
- 化学风险评估 化学风险评估 化学风险评估
背景情况:
- 人类同时接触多种物质,需要对混合物进行毒性评估.
- 化学混合物的体外试验面临着由于日常实验变化的挑战.
- 目前的方法依赖于来自多个实验的EC50值,这些值可能会受到变异性的影响.
研究的目的:
- 开发一种在体外混合物毒性测试中调整日复一日的变异性的程序.
- 通过考虑实验不一致性,使混合物毒性的可靠评估成为可能.
- 为探索混合物中的物质相互作用引入参考模型.
主要方法:
- 一种新的方法,使用每种物质单一的度与混合物一起测试.
- 实施一种附加模型,称为"预算方法",作为参考.
- 在初始实验中确定度-反应关系和EC20值.
主要成果:
- 拟议的程序有效地调整混合物毒性实验中的日常变化.
- 预算方法为识别协同或对抗相互作用提供了可靠的参考.
- 在参考度下观察到的生存能力更准确地确定.
结论:
- 开发的方法提高了体外混合物毒性测试的可靠性.
- 这种方法提供了一种更强大的方法来评估化学混合物的风险.
- 预算方法是了解复杂混合物中的物质相互作用的宝贵工具.
相关概念视频
Drug Concentration Versus Time Correlation
1.2K
The plasma drug concentration-time curve is a crucial tool in pharmacokinetics, representing the drug's concentration in plasma at different time intervals post-administration. This curve illustrates the drug's journey from absorption into the systemic circulation, distribution to body tissues, and eventual elimination through excretion or biotransformation.
Two pivotal parameters are the minimum effective concentration (MEC) and the minimum toxic concentration (MTC). The MEC is the...
Two pivotal parameters are the minimum effective concentration (MEC) and the minimum toxic concentration (MTC). The MEC is the...
1.2K
Mechanistic Models: Compartment Models in Individual and Population Analysis
86
Mechanistic models are utilized in individual analysis using single-source data, but imperfections arise due to data collection errors, preventing perfect prediction of observed data. The mathematical equation involves known values (Xi), observed concentrations (Ci), measurement errors (εi), model parameters (ϕj), and the related function (ƒi) for i number of values. Different least-squares metrics quantify differences between predicted and observed values. The ordinary least...
86
One-Compartment Open Model: Wagner-Nelson and Loo Riegelman Method for ka Estimation
710
This lesson introduces two critical methods in pharmacokinetics, the Wagner-Nelson and Loo-Riegelman methods, used for estimating the absorption rate constant (ka) for drugs administered via non-intravenous routes. The Wagner-Nelson method relates ka to the plasma concentration derived from the slope of a semilog percent unabsorbed time plot. However, it is limited to drugs with one-compartment kinetics and can be impacted by factors like gastrointestinal motility or enzymatic degradation.
On...
On...
710
One-Compartment Open Model for IV Bolus Administration: Estimation of Elimination Rate Constant, Half-Life and Volume of Distribution
495
The one-compartment open model is a simplified approach used in pharmacokinetics to understand the distribution and elimination of a drug administered through an intravenous bolus. This model assumes rapid drug dispersal throughout the body and elimination using a first-order process. Key pharmacokinetic parameters, such as the elimination rate constant (k), half-life (t1/2), and the apparent volume of distribution (Vd), can be estimated from this model. The elimination rate is calculated...
495
Two-Compartment Open Model: Extravascular Administration
321
The two-compartment model for extravascular administration represents a drug's absorption and distribution process. It features a central compartment, where the drug is first absorbed, and a peripheral compartment, which illustrates the drug's distribution throughout the body. The rate of change in drug concentration in the central compartment is calculated by three exponents: absorption, distribution, and elimination.
The absorption exponent (ka) indicates the speed at which the drug...
The absorption exponent (ka) indicates the speed at which the drug...
321
Drug Concentrations: Measurements
582
Drug concentration is the quantity of a drug present in a biological sample. Measuring drug amounts in biological samples allows the clinician to understand how a drug is absorbed, distributed, metabolized, and excreted. Samples can be obtained through invasive or non-invasive methods. Invasive techniques involve surgical or parenteral interventions to gather blood, cerebrospinal fluid, or tissue biopsy. Conversely, non-invasive approaches provide samples like urine, feces, and saliva.
Plasma...
Plasma...
582


